Balancing the NIMH Portfolio - Chart Descriptions
Figure 1 shows the percent of total funding in the three Research Areas (therapeutics development and services; disease-related basic; and fundamental basic) from 2007 to 2020. Fundamental basic research received the lowest percentage of funding, changing from just 11.3% in 2007 and rising to 18.7% in 2020. Between 2007 and 2020, therapeutic development and services research and disease-related basic research have received between approximately 35% and 50% of funding. Therapeutics development and services research received a higher percentage of funding than disease-related basic research from 2007 to 2012 and from 2017 to 2020. From 2012 to 2017, disease-related basic research received a higher percentage of funding than did therapeutics development and services research.
Figure 2 shows the total paid amount in millions of dollars for NIMH funding in suicide prevention research from 2010 to 2020. The total paid amounts in millions in 2010 was approximately $16.3 million. From 2011 to 2013, funding fell from approximately $22.5 million to $16.9 million. Since 2013, funding has either remained relatively stable or increased year-over-year. Total funding in 2020 was approximately $59.9 million.
Figure 3 shows the proportion of NIMH and NIH research funding supporting clinical trials from 2008 to 2020. Across all years, NIMH spent a greater proportion of total funding on clinical trials support than NIH. NIMH spent between 10.9% and 17.7% of total funding on clinical trials support between 2008 and 2020. NIH spent between 10.0% and 15.9% of total funding in clinical trials support. The proportion of funding has fluctuated for both NIMH and NIH from 2008 through 2016 and increased consistently from 2017 through 2020.